Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Unaudited)

v3.23.2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income/(Loss)
Employees
Common Stock
Executive Officer
Common Stock
Director
Common Stock
Beginning balance (in shares) at Mar. 31, 2022   33,364,722            
Beginning balance at Mar. 31, 2022 $ 399,204 $ 33 $ 234,549 $ 203,528 $ (38,906)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           30,352 64,294 8,766
Stock compensation expense 1,193   1,193          
Repurchase of employee stock units on vesting (552)   (552)          
Net income 6,556     6,556        
Foreign currency translation adjustment (5,152)       (5,152)      
Other 3       2      
Ending balance (in shares) at Jun. 30, 2022   33,468,134            
Ending balance at Jun. 30, 2022 $ 401,252 $ 33 235,190 210,085 (44,056)      
Beginning balance (in shares) at Mar. 31, 2023 33,508,076 33,508,076            
Beginning balance at Mar. 31, 2023 $ 418,988 $ 33 239,860 237,195 (58,100)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           73,345 93,826 5,718
Stock compensation expense 1,238   1,238          
Repurchase of employee stock units on vesting (1,685)   (1,685)          
Net income 10,938     10,938        
Foreign currency translation adjustment 4,457     0 4,457      
Other $ 13     0 13      
Ending balance (in shares) at Jun. 30, 2023 33,680,965 33,680,965            
Ending balance at Jun. 30, 2023 $ 433,949 $ 33 $ 239,413 $ 248,133 $ (53,630)